MCAS

Lactobacillus rhamnosus GG (LGG) in Mast Cell Activation Syndrome: A Strain-Specific Review of the Clinical and Mechanistic Evidence

MCAS

Lactobacillus rhamnosus GG (LGG) in Mast Cell Activation Syndrome: A Strain-Specific Review of the Clinical and Mechanistic Evidence

Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine  |  Integrative & Functional Medicine Physician MEDICAL DISCLAIMER This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Mast Cell Activation Syndrome (MCAS) and histamine intolerance are highly individualized conditions, and probiotic responses can vary

By Yoon Hang Kim MD
CIRS vs. MCAS: Understanding Two Overlapping but Distinct Chronic Inflammatory Conditions

CIRS

CIRS vs. MCAS: Understanding Two Overlapping but Distinct Chronic Inflammatory Conditions

By Yoon Hang Kim, MD, MPH  |  Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Chronic illness patients — especially those navigating mold illness, Lyme disease, autoimmune conditions, or post-infectious syndromes — frequently encounter two acronyms that are both confusing and critically important: CIRS and MCAS. These conditions share a

By Yoon Hang Kim MD
Vitamin D as a Mast Cell–Modulating Hormone:Mechanistic Evidence, Clinical Implications, and Relevance to Mast Cell Activation Syndrome

MCAS

Vitamin D as a Mast Cell–Modulating Hormone:Mechanistic Evidence, Clinical Implications, and Relevance to Mast Cell Activation Syndrome

Yoon Hang “John” Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine MD www.directintegrativecare.com Abstract Vitamin D has emerged as a pleiotropic immunomodulatory hormone with significant effects on mast cell biology. Mast cells, which are central effectors in allergic disease and increasingly recognized as drivers

By Yoon Hang Kim MD
See all